PGC-1-ALPHA-MODULIERENDE PEPTIDE
European patent · EP2651428 · In force
Register entry
- Publication number
- EP2651428
- Application number
- EP12710106
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Mar 23, 2012
- Published
- Oct 23, 2013
- Granted
- Aug 3, 2016
- Protection ends at the latest
- Mar 22, 2032
- Next annual fee due
- Mar 31, 2027
- IPC classes
- A61K 38/04 (2006.01)C07K 7/06 (2006.01)
- Priority
- ES 201130439 25.03.2011US 201161467648 P 25.03.2011
- PCT application
- PCT/EP2012/055259 23.03.2012
- PCT publication
- WO2012/130775 04.10.2012
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Apr 1, 2026
Change
Published in Swissreg on 01.04.2026
- Apr 1, 2025
Change
Published in Swissreg on 01.04.2025
- Apr 2, 2024
Change
Published in Swissreg on 02.04.2024
- Apr 1, 2023
Change
Published in Swissreg on 01.04.2023
- Jan 9, 2023
Address changed
- Representative
- ServoPatent GmbH, Wannerstrasse 9/1, 8045 Zürich → Servopatent GmbH, Bühlstrasse 1, 8125 Zollikerberg
Published in Swissreg on 09.01.2023
- Jun 4, 2020
Address changed
- Representative
- Servopatent GmbH, Resirain 1, 8125 Zollikerberg → ServoPatent GmbH, Wannerstrasse 9/1, 8045 Zürich
Published in Swissreg on 04.06.2020
- Oct 18, 2016
Agent entered
- Representative
- Servopatent GmbH, Resirain 1, 8125 Zollikerberg
Published in Swissreg on 18.10.2016
- Aug 3, 2016
Granted
Published in Swissreg on 03.08.2016
Parties
Holder
Inventor
E-08017 Barcelona, ES
E-08030 Barcelona, ES
E-03540 Alicante, ES
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.